Evaluation of the CR Neuromodulation Treatment for Tinnitus

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

February 28, 2014

Study Completion Date

February 28, 2014

Conditions
Tinnitus
Interventions
DEVICE

CR Neuromodulation

"Ear level device which delivers patterned sound stimulation.~The experimental arm will use the device fitted according to audiologist training given by the manufacturer/funder. An individually specified sound stimulation algorithm is hypothesised to interrupt tinnitus generating activity in the brain. For the first 12 weeks participants will be asked to wear the device every day for 6 hours, and in blocks of time not less than 1 hour. After 12 weeks participants will be unblinded and continue with the same experimental intervention. In weeks 13-36 participants will be asked to wear the device every day for 4 hours, in continuous blocks of at least 1 hour."

DEVICE

Tinnitus masking

The active comparator uses the same ear level device and also delivers patterned sound but the stimulus will be determined according to an algorithm predicted not to break up tinnitus generating activity in the brain. It may have a masking effect. For the first 12 weeks participants will be asked to wear the device every day for 6 hours, and in blocks of time not less than 1 hour. After 12 weeks, the participants will be unblinded and the device algorithm will be reprogrammed in the same way as the experimental intervention. In weeks 13-24 participants will be asked to wear the device for 6 hours per day, in continuous blocks of at least 1 hour. In weeks 25-36 they will be asked to continue using the device every day for 4 hours, in continuous blocks of at least 1 hour.

Trial Locations (2)

WC1X 8EE

University College London Ear Institute, London

NG1 5DU

NIHR Nottingham Hearing Biomedical Research Unit, University of Nottingham, Nottingham

All Listed Sponsors
collaborator

University of Nottingham

OTHER

collaborator

University College, London

OTHER

lead

Nottingham University Hospitals NHS Trust

OTHER

NCT01541969 - Evaluation of the CR Neuromodulation Treatment for Tinnitus | Biotech Hunter | Biotech Hunter